→
Johnson & Johnson's current price of $226.71 reflects a 1.77% decline from the previous close of $230.80. With a market cap of $545.74B, the company reported a revenue growth of 7.87% YoY despite a negative EPS growth of 3.89%, indicating mixed performance. The P/E ratio stands at 26.12, suggesting that the stock may be overvalued given the stagnation in earnings.
Hold JNJ as the mixed indicators suggest uncertainty in short-term performance.
If Johnson & Johnson can leverage its 7.87% revenue growth to stabilize earnings, it could reverse the negative EPS trend. The firm's strong market position and dividend yield of 2.32% make it an attractive option for long-term investors.
The negative EPS growth of 3.89% raises concerns about future profitability, especially with a high P/E ratio of 26.12. Additionally, the stock's recent price drop of 1.77% could indicate declining investor confidence.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates JNJ as Neutral. Hold JNJ as the mixed indicators suggest uncertainty in short-term performance.
The negative EPS growth of 3.89% raises concerns about future profitability, especially with a high P/E ratio of 26.12. Additionally, the stock's recent price drop of 1.77% could indicate declining investor confidence.
If Johnson & Johnson can leverage its 7.87% revenue growth to stabilize earnings, it could reverse the negative EPS trend. The firm's strong market position and dividend yield of 2.32% make it an attractive option for long-term investors.
Johnson & Johnson's current price of $226.71 reflects a 1.77% decline from the previous close of $230.80. With a market cap of $545.74B, the company reported a revenue growth of 7.87% YoY despite a negative EPS growth of 3.89%, indicating mixed performance. The P/E ratio stands at 26.12, suggesting that the stock may be overvalued given the stagnation in earnings.
Johnson & Johnson's current price of $226.71 reflects a 1.77% decline from the previous close of $230.80. With a market cap of $545.74B, the company reported a revenue growth of 7.87% YoY despite a negative EPS growth of 3.89%, indicating mixed performance. The P/E ratio stands at 26.12, suggesting that the stock may be overvalued given the stagnation in earnings. Our overall verdict is Neutral.
Helm Terminal offers free AI-powered stock analysis for JNJ at helmterminal.dev/analyze/JNJ, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.